法令 发表于 2025-3-21 16:36:11
书目名称Multiple Primary Malignant Neoplasms影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0641015<br><br> <br><br>书目名称Multiple Primary Malignant Neoplasms影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0641015<br><br> <br><br>书目名称Multiple Primary Malignant Neoplasms网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0641015<br><br> <br><br>书目名称Multiple Primary Malignant Neoplasms网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0641015<br><br> <br><br>书目名称Multiple Primary Malignant Neoplasms被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0641015<br><br> <br><br>书目名称Multiple Primary Malignant Neoplasms被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0641015<br><br> <br><br>书目名称Multiple Primary Malignant Neoplasms年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0641015<br><br> <br><br>书目名称Multiple Primary Malignant Neoplasms年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0641015<br><br> <br><br>书目名称Multiple Primary Malignant Neoplasms读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0641015<br><br> <br><br>书目名称Multiple Primary Malignant Neoplasms读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0641015<br><br> <br><br>animated 发表于 2025-3-21 20:45:48
Charles G. Moertel (Consultant, Assistant Professo适宜 发表于 2025-3-22 01:49:04
http://reply.papertrans.cn/65/6411/641015/641015_3.pngArroyo 发表于 2025-3-22 05:44:15
http://reply.papertrans.cn/65/6411/641015/641015_4.pngOphthalmoscope 发表于 2025-3-22 10:46:19
https://doi.org/10.1007/978-3-642-87565-6carcinoma; clinic; diagnosis; oncologyobstinate 发表于 2025-3-22 14:50:54
978-3-642-87567-0Springer-Verlag Berlin Heidelberg 1966Antagonist 发表于 2025-3-22 17:54:43
Multiple Primary Malignant Neoplasms978-3-642-87565-6Series ISSN 0080-0015 Series E-ISSN 2197-6767inflate 发表于 2025-3-23 01:02:12
http://reply.papertrans.cn/65/6411/641015/641015_8.png全面 发表于 2025-3-23 03:07:21
Book 1966sponsibility for impressing the patient with the necessity for frequent and regular follow-up examinations. These examinations must be done at no longer than 1-year intervals for at least 5 years after treatment of the initial lesion and preferably at yearly intervals thereafter. 5. A minimal followRAGE 发表于 2025-3-23 06:37:25
10楼